PTJ
THC icon

Paul Tudor Jones’s Tenet Healthcare THC Stock Holding History

Paul Tudor Jones’s Portfolio THC Stock Details THC Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$16.3M Buy
87,100
+85,500
+5,344% +$15.7M 0.02% 583
2026
Q1 		$302K Buy
1,600
+400
+33% +$84.3K ﹤0.01% 3131
2025
Q4 		$238K Buy
+1,200
New +$243K ﹤0.01% 3187
2025
Q3 		– Sell
-3,400
Closed -$598K – 3886
2025
Q2 		$598K Sell
3,400
-6,100
-64% -$918K ﹤0.01% 2472
2025
Q1 		$1.28M Sell
9,500
-10,600
-53% -$1.4M ﹤0.01% 1650
2024
Q4 		$2.54M Sell
20,100
-20,600
-51% -$3.06M 0.01% 1090
2024
Q3 		$6.76M Buy
40,700
+35,500
+683% +$5.37M 0.02% 575
2024
Q2 		$692K Buy
5,200
+1,300
+33% +$156K ﹤0.01% 1659
2024
Q1 		$410K Buy
+3,900
New +$350K ﹤0.01% 1735
2023
Q3 		– Sell
-5,400
Closed -$439K – 2873
2023
Q2 		$439K Buy
+5,400
New +$384K 0.01% 1784
2023
Q1 		– Sell
-17,500
Closed -$854K – 2945
2022
Q4 		$854K Buy
+17,500
New +$809K 0.02% 1218
2022
Q2 		– Sell
-3,000
Closed -$258K – 2506
2022
Q1 		$258K Sell
3,000
-1,700
-36% -$140K 0.01% 1639
2021
Q4 		$384K Sell
4,700
-3,600
-43% -$263K 0.01% 1665
2021
Q3 		$552K Buy
+8,300
New +$589K 0.01% 1587

Other funds holding THC

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return
Boston Partners
Boston Partners Boston, Massachusetts $113B AUM 38.87% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
GCM
Glenview Capital Management New York $5.49B AUM 46.89% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Citadel Advisors
Citadel Advisors Miami, Florida $875B AUM 40.91% 1-Year Est. Return

Paul Tudor Jones's THC Position: Q4 2025 in Review

Paul Tudor Jones sold out of Tenet Healthcare (THC) in Q4 2025, closing a stake of 9,105 shares — an estimated $1.84M sold.

Paul Tudor Jones first reported a position in THC in Q2 2013 and held it in 21 quarters. The position peaked at $4.02M in Q4 2023. 705 funds tracked by Wall St. Rank hold THC as of Q4 2025.

  • Paul Tudor Jones reported no remaining Tenet Healthcare position as of Q4 2025 after selling out during the quarter.
  • Paul Tudor Jones sold 9,105 Tenet Healthcare shares in Q4 2025, an estimated $1.84M.
  • Paul Tudor Jones first reported a position in Tenet Healthcare in Q2 2013 and held it in 21 quarters.
  • Paul Tudor Jones's Tenet Healthcare position peaked at $4.02M in Q4 2023.
  • 705 funds tracked by Wall St. Rank held Tenet Healthcare as of Q4 2025.

Based on Tudor Investment Corp's 13F filing for Q4 2025, filed 17 Feb 2026.